MAPT and Alzheimer disease: ReS19‐T binds to septins to inhibit pathological SOCC activation, restoring calcium homeostasis and mitigating β‐amyloid plaque and hyperphosphorylated tau aggregate formation, thereby protecting against AD (Princen et al. 2024).